National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 31334 [07-2797]
Download as PDF
31334
Federal Register / Vol. 72, No. 108 / Wednesday, June 6, 2007 / Notices
93.306, 93.333, National Institutes of Health,
HHS)
Dated: May 30, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2795 Filed 6–5–07; 8:45 am]
BILLING CODE 4140–07–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
jlentini on PROD1PC65 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Enabling Technologies for Tissue
Engineering and Regenerative Medicine.
Date: July 18, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Columbia Hotel, 10207
Wincopin Circle, Columbia, MD 21044.
Contact Person: David A. Wilson, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7204, Bethesda, MD 20892–7924, 301–435–
0299, wilsonda2@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Ancillary Studies in Clinical Trials.
Date: July 19, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hills
Road, Bethesda, MD 20814.
Contact Person: Yingying Li-Smerin, MD,
PhD, Scientific Review Administrator,
Review Branch/DERA, National Heart, Lung,
and Blood Institute, 6701 Rockledge Drive,
Room 7184, Bethesda, MD 20892–7924, 301–
435–0277, lismerin@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Patient Oriented Research (K23, 24, and 25’s)
and Career Enhancement Award for Stem
Cell Research.
VerDate Aug<31>2005
16:59 Jun 05, 2007
Jkt 211001
Date: July 26–27, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Marriott Crystal City,
2899 Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Mark Roltsch, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892–7924, 301–435–
0287, roltschm@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 29, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2797 Filed 6–5–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Ancillary Clinical
Research Studies.
Date: June 27, 2007.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michael W. Edwards, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 750, 6707 Democracy
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Boulevard, Bethesda, MD 20892–5452, (301)
594–8886, edwardsm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Predict Outcomes in
Diabetes.
Date: June 28, 2007.
Time: 1:30 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Michael W. Edwards, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 750, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–8886, edwardsm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Nutrition and
Metabolic Studies in Youth with Type 1 DM:
SEARCH Ancillary Study.
Date: July 16, 2007.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracry
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Paul A. Rushing, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 747, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–8895, rushingp@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, Chronic Kidney
Disease Ancillary Studies.
Date: July 17, 2007.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Carol J. Goter-Robinson,
PhD, Scientific Review Administrator,
Review Branch, DEA, NIDDK, National
Institutes of Health, Room 748, 6707
Democracy Boulevard, Bethesda, MD 20892–
5452, (301) 594–7791,
goterrobinsonc@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel, ZDK1 GRB–N 01.
Date: July 27, 2007.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: D.G. Patel, PhD, Scientific
Review Administrator, Review Branch, DEA,
NIDDK, National Institutes of Health, Room
914, 6707 Democracy Boulevard, Bethesda,
MD 20892–5452, (301) 594–7682,
pateldg@niddk.nih.gov.
E:\FR\FM\06JNN1.SGM
06JNN1
Agencies
[Federal Register Volume 72, Number 108 (Wednesday, June 6, 2007)]
[Notices]
[Page 31334]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-2797]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Enabling Technologies for Tissue Engineering
and Regenerative Medicine.
Date: July 18, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Columbia Hotel, 10207 Wincopin Circle, Columbia,
MD 21044.
Contact Person: David A. Wilson, PhD, Scientific Review
Administrator, Review Branch/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7204, Bethesda, MD 20892-7924,
301-435-0299, wilsonda2@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Ancillary Studies in Clinical Trials.
Date: July 19, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hills Road, Bethesda, MD
20814.
Contact Person: Yingying Li-Smerin, MD, PhD, Scientific Review
Administrator, Review Branch/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD 20892-7924,
301-435-0277, lismerin@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel, Patient Oriented Research (K23, 24, and
25's) and Career Enhancement Award for Stem Cell Research.
Date: July 26-27, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard Marriott Crystal City, 2899 Jefferson Davis
Highway, Arlington, VA 22202.
Contact Person: Mark Roltsch, PhD, Scientific Review
Administrator, Review Branch/DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7192, Bethesda, MD 20892-7924,
301-435-0287, roltschm@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: May 29, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2797 Filed 6-5-07; 8:45 am]
BILLING CODE 4140-01-M